TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29975331

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex) preconditioning
Number of subjects: 48

Group type: COMPARATOR
Intervention: Spinal cord ischemia-reperfusion (I/R)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 48
Study: 30289907

Group type: COMPARATOR
Intervention: Unloaded condition
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Load corresponding to 20% of body mass (BM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Load corresponding to 30% of body mass (BM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Load corresponding to 40% of body mass (BM)
Number of subjects: 18
Study: 26376953

Group type: EXPERIMENTAL
Intervention: Patellar strap
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Sports tape
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control
Number of subjects: 97
Study: 24695897

Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition
Number of subjects: 33

Group type: COMPARATOR
Intervention: No nutrition (control)
Number of subjects: 33
Study: 22495696

Group type: EXPERIMENTAL
Intervention: Intensive diet and exercise intervention (Mediterranean and macrobiotic diet, moderate physical activity)
Number of subjects: 1208

Group type: COMPARATOR
Intervention: General lifestyle recommendations for cancer prevention
Number of subjects: 1208
Study: 19755402

Group type: COMPARATOR
Intervention: Tirofiban vs. Placebo
Number of subjects: 20006

Group type: COMPARATOR
Intervention: Tirofiban vs. Abciximab
Number of subjects: 20006
Study: 18663487

Group type: EXPERIMENTAL
Intervention: Intensive group training protocol (exercise therapy, back school, operant-conditioning principles)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Guideline physiotherapy (usual care according to Dutch guidelines for Low Back Pain)
Number of subjects: 114
Study: 16204716

Group type: EXPERIMENTAL
Intervention: SUV(100) normalized by serum glucose with a g-value of -0.5
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: SUV(100) normalized by serum glucose with a g-value of -0.5 in patients with extreme glucose values
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Threshold SUV(100) of 7.25
Number of subjects: 102
Study: 11846115

Group type: EXPERIMENTAL
Intervention: Cognitively-based National Cancer Institute (NCI) Diet History Questionnaire
Number of subjects: 623

Group type: COMPARATOR
Intervention: 1992 NCI-Block Health Habits and History Questionnaire
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Both approaches (cognitively-based NCI FFQ and 1992 NCI-Block FFQ)
Number of subjects: 623
Study: 10206443

Group type: EXPERIMENTAL
Intervention: TVP‐low‐cholesterol diet (17 to 30 mg/d)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: TVP (soybean protein)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard cholesterol diet (190 to 550 mg/d)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: TVP‐standard cholesterol diet
Number of subjects: 8
Study: 7639017

Group type: EXPERIMENTAL
Intervention: EcSf2a-2 vaccine strain, administered as 4 doses of ca. 7 x 10(8) c.f.u. on days 0, 3, 14, and 17
Number of subjects: 21

Group type: COMPARATOR
Intervention: Unvaccinated controls
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: EcSf2a-2 vaccine strain
Number of subjects: 21
Study: 2771322

Group type: EXPERIMENTAL
Intervention: Monovision correction; near additions of +1.50 D, +2.50 D, and no addition
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Distance contact lenses with lookover spectacles, soft progressive bifocal contact lenses, soft concentric bifocal contact lenses, monovision contact lenses, modified monovision contact lenses, hard bifocal contact lenses
Number of subjects: 18
Study: 327422

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31343675

Group type: EXPERIMENTAL
Intervention: 3D endoscopy
Number of subjects: 16

Group type: COMPARATOR
Intervention: 2D endoscopy
Number of subjects: 16
Study: 28516381

Group type: EXPERIMENTAL
Intervention: Listening to music during SWL
Number of subjects: 200

Group type: COMPARATOR
Intervention: No music during SWL (Control)
Number of subjects: 200
Study: 25223836

Group type: EXPERIMENTAL
Intervention: Selisistat 5-600 mg single dose
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Selisistat 100-300 mg once daily for 7 days
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 24358480

Group type: EXPERIMENTAL
Intervention: Retropubic midurethral sling (RMUS)
Number of subjects: 597

Group type: COMPARATOR
Intervention: Transobturator midurethral sling
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Standardized voiding trial at discharge
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Indwelling urethral catheter management
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Intermittent catheterization
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Catheter use at 2 weeks post-surgery
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Catheter use at 6 weeks post-surgery
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Preoperative voiding accommodations
Number of subjects: 597
Study: 21469386

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control (general therapy without HBO)
Number of subjects: 83
Study: 19319920

Group type: EXPERIMENTAL
Intervention: Routine use of patient-reported outcome measures (PROMs) in cancer clinics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future interventions to motivate and equip health professionals to use PROM data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future trials using cluster-randomized design
Number of subjects: 0
Study: 16483397

Group type: EXPERIMENTAL
Intervention: Long-chain polyunsaturated fatty acids (LC-PUFA) supplementation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Phenylalanine-free infant formula without LC-PUFA
Number of subjects: 42
Study: 15580812

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate with ascorbic acid (4:1 molar ratio)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate without ascorbic acid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FeSO4 with ascorbic acid (4:1 molar ratio)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FeSO4 without ascorbic acid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate (mean particle size 6.7 microm)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate (mean particle size 12.5 microm)
Number of subjects: 10
Study: 11223448

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 or 40 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9364692

Group type: EXPERIMENTAL
Intervention: 6-12 micrograms intradermal (i.d.) inoculation in three or four divided doses (Groups A-F)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: 4 micrograms intradermal (i.d.) inoculation in four doses
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (Group G) received three 10 micrograms intramuscular (i.m.) inoculations
Number of subjects: 173
Study: 7908838

Group type: EXPERIMENTAL
Intervention: Single injection of sustained-release somatuline
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Injections of sustained-release somatuline at 2-week intervals over a 6-month period
Number of subjects: 15
Study: 3126708

Group type: EXPERIMENTAL
Intervention: Bestatin combined with mitomycin C and tegafur as an adjuvant to surgery
Number of subjects: 0
Study: 31182077

Group type: EXPERIMENTAL
Intervention: Pringle Maneuver (PM) combined with stapler resection technique
Number of subjects: 106

Group type: COMPARATOR
Intervention: Stapler resection without the use of Pringle Maneuver (Control)
Number of subjects: 106
Study: 28709629

Group type: EXPERIMENTAL
Intervention: Dextrose gel
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Infant formula
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Breast feeding
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Expressed breast milk
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 227
Study: 26846591

Group type: EXPERIMENTAL
Intervention: Shared panel management program (phone call requesting appointment)
Number of subjects: 1676

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1676
Study: 23238301

Group type: EXPERIMENTAL
Intervention: Augmented feedback (AF) during tuck-jump assessment
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (CTRL) feedback during treadmill running
Number of subjects: 37
Study: 20721698

Group type: EXPERIMENTAL
Intervention: Bivalirudin (high-dose and low-dose protocols)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Heparin (standardized protocol)
Number of subjects: 90
Study: 19815903

Group type: EXPERIMENTAL
Intervention: In-person visits and telephone intervention (Telephone)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: In-person visits and telemonitoring (Telemonitoring)
Number of subjects: 303

Group type: COMPARATOR
Intervention: In-person visits alone (Control)
Number of subjects: 303
Study: 15011419

Group type: EXPERIMENTAL
Intervention: 8 mg hyperbaric bupivacaine
Number of subjects: 36

Group type: COMPARATOR
Intervention: 10 mg hyperbaric bupivacaine
Number of subjects: 36
Study: 11729746

Group type: EXPERIMENTAL
Intervention: AV decompression
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no AV decompression)
Number of subjects: 40
Study: 10225782

Group type: EXPERIMENTAL
Intervention: Sequential treatment by selective adsorption followed by intravenous IgG
Number of subjects: 45

Group type: COMPARATOR
Intervention: Plasma exchange
Number of subjects: 45

Group type: COMPARATOR
Intervention: Selective adsorption using a tryptophan-linked polyvinyl alcohol gel adsorbent
Number of subjects: 45
Study: 7716421

Group type: EXPERIMENTAL
Intervention: High competition sport group (n=52)
Number of subjects: 102

Group type: COMPARATOR
Intervention: University reference group (n=50)
Number of subjects: 102
Study: 2825746

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg) inhalation in volunteers and patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (1 mg kg‐1) oral administration in healthy volunteers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (0.2 microgram kg‐1 for 30 min) intravenous administration in healthy volunteers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg) multiple dosing four times daily for 7 days in volunteers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg) multiple dosing four times daily for 1, 6, and 12 months in patients
Number of subjects: 18
Study: 29029563

Group type: EXPERIMENTAL
Intervention: Single-session, transdiagnostic preventive intervention based on the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Number of subjects: 0
Study: 27770819

Group type: EXPERIMENTAL
Intervention: RLAS intervention schools (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care schools (n=20)
Number of subjects: 40
Study: 24362411

Group type: EXPERIMENTAL
Intervention: Combined treatment with metformin (1000 mg BID) and liraglutide (1.2 mg QD s.c.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Liraglutide (1.2 mg QD s.c.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metformin (1000 mg BID)
Number of subjects: 40
Study: 22130118

Group type: EXPERIMENTAL
Intervention: Extended run-in group (4 weeks of pre-TQD varenicline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard run-in group (3 weeks of placebo, 1 week of pre-TQD varenicline)
Number of subjects: 60
Study: 20432794

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) including CPAP and NIPPV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIV protocol in use at the University Lewisham Hospital
Number of subjects: 0
Study: 18208361

Group type: EXPERIMENTAL
Intervention: Combined pneumatic and ultrasonic lithotrite (PUL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard ultrasonic lithotrite (SUL)
Number of subjects: 30
Study: 15867182

Group type: EXPERIMENTAL
Intervention: Intravenous milrinone
Number of subjects: 949

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 949
Study: 12637459

Group type: EXPERIMENTAL
Intervention: Doxorubicin 50 mg/m² plus docetaxel 75 mg/m² (AT)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Doxorubicin 60 mg/m² plus cyclophosphamide 600 mg/m² (AC)
Number of subjects: 429
Study: 11078283

Group type: EXPERIMENTAL
Intervention: Beta irradiation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gamma irradiation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 8626853

Group type: EXPERIMENTAL
Intervention: Daily sc GH treatment at a dose of 0.2 or 0.3 IU/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 50
Study: 10135638

Group type: EXPERIMENTAL
Intervention: Structured review form
Number of subjects: 25

Group type: COMPARATOR
Intervention: Historic worksheet
Number of subjects: 25
Study: 3569765

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid enema
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 29216569

Group type: EXPERIMENTAL
Intervention: Warm handoff
Number of subjects: 25

Group type: COMPARATOR
Intervention: Fax referral
Number of subjects: 25
Study: 27165954

Group type: EXPERIMENTAL
Intervention: Admission heart rate ≥85 bpm
Number of subjects: 3185

Group type: COMPARATOR
Intervention: Admission heart rate
Number of subjects: 3185
Study: 24220224

Group type: EXPERIMENTAL
Intervention: Treadmill training (15 min) plus conventional therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 30
Study: 20609531

Group type: EXPERIMENTAL
Intervention: Practitioner-delivered brief advice
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letters
Number of subjects: 1334
Study: 18261177

Group type: EXPERIMENTAL
Intervention: Ganciclovir prophylaxis
Number of subjects: 148
Study: 15699836

Group type: EXPERIMENTAL
Intervention: rhIL-10 (1, 10, or 25 microg/kg) administered 2 mins before lipopolysaccharide (4 ng/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: rhIL-10 (1, 10, or 25 microg/kg) administered 2 hrs before lipopolysaccharide (4 ng/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (lipopolysaccharide alone)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: rhIL-10 (1, 10, or 25 microg/kg)
Number of subjects: 24
Study: 14664657

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750mg once daily for 7-14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500mg once daily for 7-14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750mg once daily for 5 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500mg once daily for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500mg once daily for 10-14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500mg once daily for 28 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500mg once daily for 7-10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750mg for 7-14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 0
Study: 11392068

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prochlorperazine 5 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9% 4 mL)
Number of subjects: 120
Study: 8806903

Group type: EXPERIMENTAL
Intervention: BAY u 3405 (50 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1634480

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg tablet twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sucralfate 1 g four times a day
Number of subjects: 40
Study: 4067974

Group type: EXPERIMENTAL
Intervention: Breathing 28% oxygen for 2-hour periods
Number of subjects: 6

Group type: COMPARATOR
Intervention: Breathing air for 2-hour periods
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Administration of oxygen
Number of subjects: 6
Study: 29778861

Group type: EXPERIMENTAL
Intervention: Hemodynamic optimization
Number of subjects: 401

Group type: COMPARATOR
Intervention: Echocardiographic optimization
Number of subjects: 401
Study: 30006211

Group type: EXPERIMENTAL
Intervention: Changes in outdoor time
Number of subjects: 145
Study: 27687350

Group type: EXPERIMENTAL
Intervention: TAP blocks (n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: OSTAP blocks (n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) only (n = 20)
Number of subjects: 60
Study: 24846173

Group type: EXPERIMENTAL
Intervention: Vagal nerve stimulation (VNS) system in active mode
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vagal nerve stimulation (VNS) system in inactive mode
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vagal nerve stimulation (VNS) system (after 6 months)
Number of subjects: 0
Study: 22529197

Group type: EXPERIMENTAL
Intervention: High-fat (HF) overfeeding diet for 5 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 46
Study: 21035069

Group type: EXPERIMENTAL
Intervention: Monocanalicular silicone intubation (MCI)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Bicanalicular silicone intubation (BCI)
Number of subjects: 57
Study: 18443868

Group type: EXPERIMENTAL
Intervention: Box trainer (natural force feedback)
Number of subjects: 19

Group type: COMPARATOR
Intervention: VR trainer (no force feedback)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Box trainer and VR trainer
Number of subjects: 19
Study: 16045136

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 47

Group type: COMPARATOR
Intervention: Regional anaesthesia
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both anaesthesia types
Number of subjects: 47
Study: 12237770

Group type: EXPERIMENTAL
Intervention: Randomised patients treated with local excision and radiotherapy
Number of subjects: 910

Group type: COMPARATOR
Intervention: Non-entered patients treated with local excision and radiotherapy
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Patients treated with local excision alone (both groups)
Number of subjects: 910
Study: 10406187

Group type: EXPERIMENTAL
Intervention: AdoMet (1200 mg/day, orally)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 7756795

Group type: EXPERIMENTAL
Intervention: Human surfactant therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surfactant therapy
Number of subjects: 0
Study: 2256759

Group type: EXPERIMENTAL
Intervention: Octreotide acetate (100 micrograms)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chronic daily treatment with octreotide acetate
Number of subjects: 16
Study: 375460

Group type: EXPERIMENTAL
Intervention: Levamisole treatment (3 days before operation and 3 days a fortnight thereafter)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 318
Study: 31941389

Group type: EXPERIMENTAL
Intervention: Deep inspirations (DIs) - 60 DIs to total lung capacity immediately pre-high-fat meal (HFM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control condition (no DIs pre-HFM)
Number of subjects: 16
Study: 30740923

Group type: EXPERIMENTAL
Intervention: Bilateral medial rectus plication (BMRP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Bilateral medial rectus resection (BMRR)
Number of subjects: 55
Study: 26895152

Group type: EXPERIMENTAL
Intervention: Acculturated Latino parents (English-speaking)
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: English-speaking Latino parents
Number of subjects: 686

Group type: COMPARATOR
Intervention: Spanish-speaking Latino parents and non-Latino white parents
Number of subjects: 686

Group type: COMPARATOR
Intervention: Less acculturated Latino parents
Number of subjects: 686
Study: 25808050

Group type: EXPERIMENTAL
Intervention: Apheresis prepared platelets (APCs)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Random donor platelets (RDPs)
Number of subjects: 15
Study: 23085682

Group type: EXPERIMENTAL
Intervention: SAME macaroni and cheese
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: SIMILAR types of macaroni and cheese
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: VARIETY of high‐energy‐dense foods
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: SAME high‐energy‐dense entrees
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: SIMILAR high‐energy‐dense entrees
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: VARIETY of high‐energy‐dense entrees
Number of subjects: 61
Study: 18832745

Group type: EXPERIMENTAL
Intervention: Blacks
Number of subjects: 505

Group type: COMPARATOR
Intervention: Whites
Number of subjects: 505
Study: 17584349

Group type: EXPERIMENTAL
Intervention: Adherence therapy (8 weekly sessions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 32
Study: 15101598

Group type: EXPERIMENTAL
Intervention: Cemented implant‐supported single‐tooth crown
Number of subjects: 12

Group type: COMPARATOR
Intervention: Screw‐retained implant‐supported single‐tooth crown
Number of subjects: 12
Study: 11434356

Group type: EXPERIMENTAL
Intervention: L-arginine supplementation (0.1 g/kg body weight/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 9504626

Group type: COMPARATOR
Intervention: Previously treated MM patients on treatment (n = 60)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Previously treated MM patients off treatment (n = 45)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Newly diagnosed MM patients (n = 58)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: CD19+ cell levels above 125/microl
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Patients with >395 CD4 cells/microl
Number of subjects: 268